OSCR as reported
Oscar Health, Inc. reported $15.3B of revenue over the trailing twelve months, +43% on the year before. 9 reported series are charted on this page, each one as filed.
$15.3B
Revenue, trailing twelve months · to Q2 2026 · +43% against the twelve months before
- Net Income
- $551M
Net Income · −442% year on year · trailing twelve months to Q2 2026
- Free Cash Flow
- $4.38B
Free Cash Flow · +265% year on year · trailing twelve months to Q2 2026
- Op Margin
- 1.7%
Op Margin · trailing twelve months to Q2 2026
| Series | Latest | Year on year | As of |
|---|---|---|---|
| Revenue | $15.3B | +43% | Q2 2026 |
| Net Income | $551M | −442% | Q2 2026 |
| EPS | $1.30 | −276% | Q2 2026 |
| Op Margin | 1.7% | n/a | Q2 2026 |
| Net Margin | 1.2% | n/a | Q2 2026 |
| ROE | −11% | n/a | Q2 2026 |
| ROA | −1.7% | n/a | Q2 2026 |
| ROIC | 4.1% | n/a | Q2 2026 |
| Free Cash Flow | $4.38B | +265% | Q2 2026 |
Every figure straight from the statements as filed with the SEC, no scoring, no adjustment. Open a series for its full history.
Oscar Health, Inc. (OSCR) - Revenue & ProfitRevenue & ProfitOscar Health, Inc. (OSCR)
Revenue (TTM)Net Income (TTM)
Powered byryufin.com